Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-169245
Filing Date
2021-05-21
Accepted
2021-05-21 16:04:00
Documents
61
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d172914d10ka.htm 10-K/A 410398
2 EX-31.1 d172914dex311.htm EX-31.1 9642
3 EX-31.2 d172914dex312.htm EX-31.2 9631
4 EX-32.1 d172914dex321.htm EX-32.1 5135
  Complete submission text file 0001193125-21-169245.txt   4384436

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pana-20201231.xml EX-101.INS 1053108
6 XBRL TAXONOMY EXTENSION SCHEMA pana-20201231.xsd EX-101.SCH 49874
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pana-20201231_cal.xml EX-101.CAL 22843
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pana-20201231_def.xml EX-101.DEF 220612
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pana-20201231_lab.xml EX-101.LAB 307629
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pana-20201231_pre.xml EX-101.PRE 287646
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39351 | Film No.: 21948962
SIC: 2834 Pharmaceutical Preparations